APA (7th ed.) Citation

HH, H., N, T., CL, L., WH, W., WY, L., CH, C., . . . YP, L. (2025). Impact of anti-osteoporotic treatments on hyperlipidemia risk in osteoporosis patients: Evidence from a population-based retrospective cohort study. European journal of medical research, 30(1), 852. https://doi.org/10.1186/s40001-025-03130-0

Chicago Style (17th ed.) Citation

HH, Hsieh, et al. "Impact of Anti-osteoporotic Treatments on Hyperlipidemia Risk in Osteoporosis Patients: Evidence from a Population-based Retrospective Cohort Study." European Journal of Medical Research 30, no. 1 (2025): 852. https://doi.org/10.1186/s40001-025-03130-0.

MLA (9th ed.) Citation

HH, Hsieh, et al. "Impact of Anti-osteoporotic Treatments on Hyperlipidemia Risk in Osteoporosis Patients: Evidence from a Population-based Retrospective Cohort Study." European Journal of Medical Research, vol. 30, no. 1, 2025, p. 852, https://doi.org/10.1186/s40001-025-03130-0.